Nuvalent Inc (NUVL)
69.25
-1.10
(-1.56%)
USD |
NASDAQ |
May 06, 16:00
69.25
0.00 (0.00%)
After-Hours: 18:49
Nuvalent Cash and Short Term Investments (Quarterly): 719.90M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 719.90M |
| September 30, 2023 | 413.26M |
| June 30, 2023 | 431.24M |
| March 31, 2023 | 450.46M |
| December 31, 2022 | 472.16M |
| September 30, 2022 | 240.06M |
| June 30, 2022 | 256.96M |
| Date | Value |
|---|---|
| March 31, 2022 | 272.73M |
| December 31, 2021 | 288.11M |
| September 30, 2021 | 302.43M |
| June 30, 2021 | 138.92M |
| March 31, 2021 | 14.40M |
| December 31, 2020 | 10.33M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
10.33M
Minimum
Dec 2020
719.90M
Maximum
Dec 2023
308.54M
Average
288.11M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Geron Corp | 443.05M |
| Verastem Inc | 137.13M |
| Karyopharm Therapeutics Inc | 191.44M |
| Syndax Pharmaceuticals Inc | 577.58M |
| AnaptysBio Inc | 390.90M |